HAEMOLYTIC ANAEMIA HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam.

Slides:



Advertisements
Similar presentations
Normocytic Anemia David Lee, MD, FRCPC. Normocytic anemia a heterogenous group of anemias normocytosis implies normal DNA metabolism and hemoglobin synthesis.
Advertisements

Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Lecturer /Sulaimani College of Medicine/ Dept.of Pathology
In the name of GOD.
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Date : 26/12/2013 Outcome : The student will know : -The types of.
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
HEMOLYTIC ANEMIA HOSEA NJOKU 1405.
Hemolytic Anemias due to Other Intracorpuscular Defects
increase red cell destruction = reduced red-cell life span
HEMOLYTIC ANEMIAS. HEMOLYTIC ANEMIA Anemia of increased destruction –Normochromic, normochromic anemia –Shortened RBC survival –Reticulocytosis - Response.
 Charachterized by:  A nemia results when the rate of destruction exceeds the capacity of the m arrow to produce RBCs(The bone marro 8 times increased.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The types of hemolytic anemias.
Week 2: Hemolytic Anemia
Introduction to Hemolytic Anemias
Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis)
Splenectomy in Hematologic Disorders
Anaemia By Jeeves.
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
HEREDITARY/ACQUIRED HEMOLYTIC ANEMIA
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Haemolytic Anaemia Elliot Catchpole PCMD.
LS/MW MT 417 – Clinical Hematology II Manual/Special Tests Unit Ham’s/Sugar Water/DL Exercise Ham’s/Sugar Water/DL Questions KEY.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
Haemolytic anaemias Dr. Suhair Abbas Ahmed.
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Nada Mohamed Ahmed , MD, MT (ASCP)i
Acquired haemolytic anaemias
Auto Immune hemolytic anemia
Hemolytic anemias.
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
Acquired Haemolytic Anaemias. Haemolytic conditions are those in which: erythrocyte construction industry is healthy (usually) red cells produced have.
HEMOLYTIC ANEMIAS.
CLASSIFICATION OF ANEMIA
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
HEMOLYTIC DESORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
Glucose-6-phosphate Dehydration Deficiency
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Anemia Presented by M.A. Kaeser, DC Fall 2009
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
HEMOLYTIC ANEMIA Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin.
Acquired Hemolytic Anemias
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
SHEIKHA HEMOLYTIC ANEMIAS. SHEIKHA Abnormalities of the Environment of the Red Cells Abnormalities of the Red Cells Premature destruction of the red cells.
HEMOLYTIC ANEMIA INCREASE RED CELL DESTRUCTION =
and BLEEDING DISORDERS
Jaundice: Causes and Etiopathogenesis
Advanced Hematology (Medi 6304)
MLAB Hematology Fall 2007 Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Anemia By: Dr Sunita Mittal.
HEMOLYTIC DISORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
溶血性贫血 Hemolytic Anemia
MLAB 1415-Hematology Keri Brophy-Martinez
Approach to Haemolysis
RED BLOOD CELLS (RBCs) Prof. Dr. Salwa Saad.
Presentation transcript:

HAEMOLYTIC ANAEMIA HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Hb 9 g%transfusion Hb 4 g% HEMOLYTIC ? HEMOLYTIC ? No sign of bleeding WHENBYTHEN

Used Drug or traditional medicine Hb decreased no sign of bleeding no sign of bleeding Hemolytic ?

Anemia + icterus (mild) Infection Hemolytic ?

Definition Any situation in which there is a reduction in RBC life-span due to increase RBC destruction. Failure of compensatory marrow response results in anemia. Predominant site of RBC destruction is red pulp of the spleen.Any situation in which there is a reduction in RBC life-span due to increase RBC destruction. Failure of compensatory marrow response results in anemia. Predominant site of RBC destruction is red pulp of the spleen.

Normositic normochromic anemia Normositic normochromic anemia Diagnostic: –MCV fL and –MCH > 27 pg or MCHC ³ 30 g/dL Cause : –Distribution failure. –Lack of production, –Rate of RBC destruction  reduced red-cell life span

OTHER HAEMOLYTIC ANAEMIAS Parasites Hypersplenism Microangiopathic haemolysis Hereditary spherocytosis Paroxysmal noctural haemoglobinuria Enzyme deficiencies Drug or toxin Haemoglobinopathies AUTO IMMUNO HAEMOLYTIC ANAEMIA Erythroblastosis foetalis Transfusion reaction Collagen vascular disease OTHER Renal disease Infection Malnutrition Aplastic anaemia Radiation MYELOPHTHISIC Tumor Myelofibrosis Infection Leukaemia BLOOD LOSS ANAEMIA REPLACEMENT OF NORMAL MARROW ELEMENTS DECREASED CELLULARITY HYPERCELLULAR ERYTHROID HYPERPLASIA POSITIVE NEGATIVE INCREASEDREDUCED NORMOCYTIC ANAEMIA INTERPRETATION LABORATORY TEST PERIPHERAL SMEAR RETICULOCYTE COUNT BLOOD IN STOOL OR OTHER SOURCE OF BLEEDING IDENTIFIED ANTIHUMAN GLOBULIN (COOMBS’TEST) BONE MARROW AND BONE MARROW BIOPSY DIAGNOSIS

Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis) 2. Metabolic defect (Glucoze-6-Phosphate-Dehydrogenaze (G6PD) deficiency, Pyruvate kinase (PK) deficiency) 3. Hemoglobinopathies (unstable hemoglobins, thalassemias, sickle cell anemia ) B. Acquired 1. Membrane abnormality-paroxysmal nocturnal hemoglobinuria (PNH)

II. Extracorpuscular factors A. Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Transfusion of incompatible blood B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria), venons 3. Hemolysis due to physical trauma - hemolytic - uremic syndrome (HUS) - thrombotic thrombocytopenic purpura (TTP) - prosthetic heart valves 4. Hypersplenism

Mechanisms of hemolysis: - Intravascular - Extravascular - Intravascular - Extravascular

Intravascular hemolysis (1): - red cells destruction occurs in vascular space - clinical states associated with Intravascular hemolysis: acute hemolytic transfusion reactions severe and extensive burns paroxysmal nocturnal hemoglobinuria severe microangiopathic hemolysis physical trauma bacterial infections and parasitic infections (sepsis)

Inravascular hemolysis (2): - laboratory signs of intravascular hemolysis: indirect hyperbilirubinemia erythroid hyperplasia hemoglobinemia methemoalbuminemia hemoglobinuria absence or reduced of free serum haptoglobin hemosiderinuria Inravascular hemolysis (2): - laboratory signs of intravascular hemolysis: indirect hyperbilirubinemia erythroid hyperplasia hemoglobinemia methemoalbuminemia hemoglobinuria absence or reduced of free serum haptoglobin hemosiderinuria

Extravascular hemolysis (1) - red cells destruction occurs in reticuloendothelial system - clinical states associated with extravascular hemolysis : autoimmune hemolysis delayed hemolytic transfusion reactions hemoglobinopathies hereditary spherocytosis hypersplenism hemolysis with liver disease

Extravascular hemolysis (2): Laboratory signs of extravascular hemolysis: indirect hyperbilirubinemia increased excretion of bilirubin by bile erythroid hyperplasia hemosiderosis Extravascular hemolysis (2): Laboratory signs of extravascular hemolysis: indirect hyperbilirubinemia increased excretion of bilirubin by bile erythroid hyperplasia hemosiderosis

Autoimmune hemolytic anemia caused by warm- reactive antibodies: I. Primary II. Secondary 1. acute - viral infections - drugs (  -Methyldopa, Penicillin, Quinine, Quinidine) 2. chronic - rheumatoid arthritis, systemic lupus erythematosus - lymphoproliferative disorders (chronic lymphocytic leukemia, lymphomas, WaldenstrÖm’s macroglobulinemia) - miscellaneous (thyroid disease, malignancy )

Autoimmune hemolytic anemia caused by cold-reactive antibodies: I. Primary cold agglutinin disease II. Secondary hemolysis: - mycoplasma infections - viral infections - lymphoproliferative disorders III. Paroxysmal cold hemoglobinuria

LABORATORY RBC abnormalities  Sel target : HbC  Fragmented RBC : schistocytes burr cells helmet cells (MAHA) Plasmodium HbCHelmet cellsBurr cellsP. falciparum

LABORATORY 2.BONE MARROW Erythroid hyperplasia: rubrisit predominant Iron stores : negative / or normal

LABORATORY 1.BLOOD FILM Microspherocyte : 1. Autoimmuno haemolytic anaemia (AIHA) 2. Hereditary spherocytosis 3. Haemoglobinopathies : HbC 4. Hipersplenisme MCV N MCH N MCHC AIHA Spherocyte

DIAGNOSIS DIAGNOSIS OF HEMOLYTIC ANAEMIA Basic steps are : 1.Evaluation of clinical information from a review of the history & physical examination 2.Evaluation of the basic blood examination & specialized laboratory examination 3.Bone marrow examination

Laboratory features: 1. Laboratory features - normocytic/macrocytic, hyperchromic anemia - reticulocytosis - increased serum iron - antiglobulin Coombs’ test is positive 2. Blood smear - anisopoikilocytosis, spherocytes - erythroblasts - schistocytes 3. Bone marrow smear - erythroid hyperplasia

Hemolytic anemia - clinical features: - pallor - jaundice - splenomegaly

Diagnosis of hemolytic syndrome: 1. Anemia 2. Reticulocytosis 3. Indirect hyperbilirubinemia Diagnosis of hemolytic syndrome: 1. Anemia 2. Reticulocytosis 3. Indirect hyperbilirubinemia

Autoimmune hemolytic anemia - diagnosis - positive Coombs’ test Autoimmune hemolytic anemia - diagnosis - positive Coombs’ test

Treatment : - steroids - splenectomy - immunosupressive agents - transfusion Treatment : - steroids - splenectomy - immunosupressive agents - transfusion

G-6PD DEFISIENSI

G-6PD deficiency X-linked disorders, heterozygote females only rarely have significant haemolysis Haemolysis cause by infection, acidosis, drugs & toxins Red blood cells membrane oxidation Precipitation of haemoglobin Heinz bodies PB smear bite cells In acute haemolytic episode G-6PD activity maybe normal

Diagnosis Diagnosis : Low level G-6PD concentration Treatment : 1. Avoid of drugs exposure. 2. Transfusion. 3. No spesific treatment. 4. Anti oksidan, ???.

Drug exposure of hemolytic. Asetanilidprimakuin Furazolidonsulfasetamid Biru metilensulfametoksazol Asam nalidixatsulfanilamid Naftalensulfapiridin Nitrofurantoinbiru toluidin Fenazopiridtrinitrotoluen Fenilhidrazinjamu

Hereditary microspherocytosis (1) 1. Pathophysiology - red cell membrane protein defects (spectrin deficiency) resulting cytoskeleton instability 2. Familly history 3. Clinical features - splenomegaly 4. Laboratory features - hemolytic anemia - blood smear-microspherocytes - abnormal osmotic fragility test - positive autohemolysis test - prevention of increased autohemolysis by including glucose in incubation medium 5. Treatment - splenectomy

A : congenital non-spherocytic anaemias B : spherocytosis Osmotic fragility test

Hereditary microspherocytosis (2) 5. Treatment : Splenectomy

Paroxysmal nocturnal hemoglobinuria (PNH). 1. Pathogenesis - an acquired clonal disease, arising from a somatic mutation in a single abnormal stem cell - glycosyl-phosphatidyl- inositol (GPI) anchor abnormality - deficiency of the GPI anchored membrane proteins (delay-accelerating factor =CD55 and a membrane inhibitor of reactive lysis =CD59) - red cells are more sensitive to the lytic effect of complement - intravascular hemolysis 2. Symptoms - passage of dark brown urine in the morning

3. PNH –laboratory features: - pancytopenia - chronic urinary iron loss - serum iron concentration decreased - hemoglobinuria - hemosiderinuria - positive Ham’s test (acid hemolysis test) - positive sugar-water test - specific immunophenotype of erytrocytes (CD59, CD55)

HAMS & SUGAR WATER TEST Paroxymal nocturnal haemoglobinuria (PNH) RBC in PNH are abnormally sensitive to lysis to complement Diagnosis can be made by : 1.Abnormal lysis of RBC by acidic serum (Ham’s tests) 2.Hypotonic medium solution (Sugar water test)

4. Treatment : - washed RBC transfusion - iron therapy - allogenic bone marrow transplantation